Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
37
MELI Quote, Financials, Valuation and Earnings
Last price:
$1,722.19
Seasonality move
:
5.37%
Day range:
$1,646.00 - $1,727.17
52-week range:
$1,324.99 - $2,161.73
Dividend yield:
0%
P/E ratio:
60.70x
P/S ratio:
4.77x
P/B ratio:
21.79x
Volume:
712K
Avg. volume:
507.7K
1-year change:
7.69%
Market cap:
$87.2B
Revenue:
$14.5B
EPS (TTM):
$28.34
Earnings Data
Next earnings date for MELI
Feb 21
2025
Most recent earnings per share
$7.83
Missed by $2.10
(Nov 6/2024)
Consensus Estimate
$9.93
(Nov 6/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
MELI Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/21/2025 | Q4 | $5.9B | -- | -- | $7.92 | -- |
| 11/06/2024 | Q3 | $5.3B | $5.3B | $7.83 | $9.93 | -$2.10 |
| 08/01/2024 | Q2 | $4.7B | $5.1B | $10.48 | $8.34 | $2.14 |
| 05/02/2024 | Q1 | $3.9B | $4.3B | $6.78 | $5.72 | $1.06 |
| 02/22/2024 | Q4 | $4.1B | $3.8B | $3.25 | $7.02 | -$3.77 |
| 11/01/2023 | Q3 | -- | -- | $7.16 | $5.68 | $1.48 |
| 08/02/2023 | Q2 | -- | -- | $5.16 | $4.10 | $1.06 |
| 05/03/2023 | Q1 | -- | -- | $3.97 | $3.31 | $0.66 |
| 02/23/2023 | Q4 | -- | -- | $3.25 | $2.62 | $0.63 |
| 11/03/2022 | Q3 | -- | -- | $2.56 | $2.43 | $0.13 |
| 08/03/2022 | Q2 | -- | -- | $2.43 | $1.93 | $0.50 |
| 05/05/2022 | Q1 | -- | -- | $1.30 | $1.41 | -$0.11 |
| 02/22/2022 | Q4 | -- | -- | -$0.92 | $1.17 | -$2.09 |
| 11/04/2021 | Q3 | -- | -- | $1.92 | $1.31 | $0.61 |
| 08/04/2021 | Q2 | -- | -- | $1.37 | $0.19 | $1.18 |
| 05/05/2021 | Q1 | -- | -- | -$0.68 | -$0.04 | -$0.64 |
| 03/01/2021 | Q4 | -- | -- | -$1.02 | $0.19 | -$1.21 |
| 11/04/2020 | Q3 | -- | -- | $0.28 | $0.26 | $0.02 |
| 08/06/2020 | Q2 | -- | -- | $1.11 | $0.16 | $0.95 |
| 05/05/2020 | Q1 | -- | -- | -$0.44 | -$0.57 | $0.13 |
| 02/10/2020 | Q4 | -- | -- | -$1.11 | -$0.79 | -$0.32 |
| 10/31/2019 | Q3 | -- | -- | -$2.96 | -$0.07 | -$2.89 |
| 08/07/2019 | Q2 | -- | -- | $0.31 | $0.32 | -$0.01 |
| 05/02/2019 | Q1 | -- | -- | $0.13 | -$0.17 | $0.30 |
| 02/26/2019 | Q4 | -- | -- | -$0.05 | -$0.11 | $0.06 |
| 11/01/2018 | Q3 | -- | -- | -$0.23 | -$0.10 | -$0.13 |
| 08/08/2018 | Q2 | -- | -- | -$0.25 | -$0.28 | $0.03 |
| 05/09/2018 | Q1 | -- | -- | -$0.29 | $0.44 | -$0.73 |
| 02/22/2018 | Q4 | -- | -- | $0.41 | $0.55 | -$0.14 |
| 11/02/2017 | Q3 | -- | -- | $0.63 | $0.62 | $0.01 |
| 08/03/2017 | Q2 | -- | -- | $0.61 | $1.06 | -$0.45 |
| 05/04/2017 | Q1 | -- | -- | $1.10 | $0.87 | $0.23 |
| 02/23/2017 | Q4 | -- | -- | $1.16 | $0.90 | $0.26 |
| 11/03/2016 | Q3 | -- | -- | $0.89 | $0.83 | $0.06 |
| 08/04/2016 | Q2 | -- | -- | $0.74 | $0.57 | $0.17 |
| 04/28/2016 | Q1 | -- | -- | $0.68 | $0.54 | $0.14 |
| 02/25/2016 | Q4 | -- | -- | $0.88 | $0.67 | $0.21 |
| 11/04/2015 | Q3 | -- | -- | $0.75 | $0.60 | $0.15 |
| 08/05/2015 | Q2 | -- | -- | $0.44 | $0.74 | -$0.30 |
| 05/06/2015 | Q1 | -- | -- | $0.78 | $0.59 | $0.19 |
| 02/25/2015 | Q4 | -- | -- | $0.76 | $0.83 | -$0.07 |
MercadoLibre Earnings Questions
-
How Much did MercadoLibre Generate in Revenue Last Quarter?
MercadoLibre reported $5.3B worth of top line sales in its most recent quarter.
-
Did MercadoLibre Beat Earnings Last Quarter?
MercadoLibre announced earnings per share of $7.83 which represents a miss of analyst forecast a $9.93 per share.
-
Is MercadoLibre Profitable?
MercadoLibre reported $2.4B that represents $48.11 per share over the last quarter.
-
What is the Analyst Consensus for MercadoLibre EPS Next Year?
MercadoLibre's earnings are forecast to grow from $19.46 per share to $23.06 per share next year representing an increase of 72.33%.
-
When is MercadoLibre's Earnings Date?
MercadoLibre's next earnings date is February 21, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
